CTMX
CytomX Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
5.38 / 10Overall Score
NeturalInvestment Rating
5.38 / 10Overall Score
NeturalInvestment Rating
Is CTMX a Good Buy Right Now?
- Based on a composite score of 5.38/10, we rate CTMX as a Netural. Our analysis breaks down into 3.98/10 for Fundamentals, 6.05/10 for Technicals, and 5.75/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of CTMX?
Is CTMX undervalued or overvalued?
What is the analyst consensus for CTMX?
Is CTMX a Good Buy Right Now?
- Based on a composite score of 5.38/10, we rate CTMX as a Netural. Our analysis breaks down into 3.98/10 for Fundamentals, 6.05/10 for Technicals, and 5.75/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CTMX undervalued or overvalued?
Technical Analysis of CTMX?
What is the analyst consensus for CTMX?
